Improving aerosol drug delivery during invasive mechanical ventilation with redesigned components

Respiratory Care

Volumn 59, Issue 5, 2014, Pages 686-698

  Longest, P Worth ^a   Mandana, Azimi ^b   Golshahi, Laleh ^b   Hindle, Michael ^b  

^a Virginia Commonwealth University   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Endotracheal tube; Improved aerosol delivery; Mechanical ventilation; Mesh nebulizer; Pharmaceutical aerosols; Respiratory drug delivery; Streamlined designs; T connector; Y connector

Indexed keywords

AEROSOL; AIRFLOW; AIRWAY CONNECTOR; ARTICLE; ARTIFICIAL VENTILATION; BREATHING CIRCUIT; COMPUTATIONAL FLUID DYNAMICS; DRUG DELIVERY SYSTEM; ENDOTRACHEAL TUBE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NEBULIZER; PARTICLE SIZE; RESPIRATORY DRUG ADMINISTRATION; SIMULATION; T CONNECTOR; VENTILATOR; Y CONNECTOR; ADMINISTRATION AND DOSAGE; COMPUTER SIMULATION; DEVICES; ENDOTRACHEAL INTUBATION; EQUIPMENT DESIGN; HUMAN; HYDRODYNAMICS; INHALATIONAL DRUG ADMINISTRATION;

AEROSOL;

ADMINISTRATION, INHALATION; AEROSOLS; COMPUTER SIMULATION; EQUIPMENT DESIGN; HUMANS; HYDRODYNAMICS; INTUBATION, INTRATRACHEAL; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; RESPIRATION, ARTIFICIAL;

EID: 84899761533     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02782     Document Type: Article

References (34)

1. Dhand R. Basic techniques for aerosol delivery during mechanical ventilation. Respir Care 2004;49(6):611-622.
2. Dhand R. Inhalation therapy in invasive and noninvasive mechanical ventilation. Curr Opin Crit Care 2007;13(1):27-38.
3. Dhand R. Aerosol delivery during mechanical ventilation: From basic techniques to new devices. J Aerosol Med Pulm Drug Deliv 2008;21(1):45-60.
4. Ari A, Fink JB. Inhalation therapy in patients receiving mechanical ventilation: an update. J Aerosol Med Pulm Drug Deliv 2012;25(6): 319-332.
5. Fuller HD, Dolovich MB, Posmituck G, Pack WW, Newhouse MT. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients: comparison of dose to the lungs. Am Rev Respir Dis 1990;141(2):440-444.
6. Fuller HD, Dolovich MB, Turpie FH, Newhouse MT. Efficiency of bronchodilator aerosol delivery to the lungs from the metered-dose inhaler in mechanically ventilated patients: a study comparing 4 different actuator devices. Chest 1994;105(1):214-218.
7. MacIntyre NR, Silver RM, Miller CW, Schuler F, Coleman RE. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 1985;13(2):81-84.
8. Fink JB, Dhand R, Duarte AG, Jenne JW, Tobin MJ. Aerosol delivery from a metered-dose inhaler during mechanical ventilation: an in vitro model. Am J Respir Crit Care Med 1996;154(2):382-387.
9. Fink JB, Dhand R, Grychowski J, Fahey PJ, Tobin MJ. Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med 1999;159(1): 63-68.
10. Dhand R. Aerosol therapy in patients receiving noninvasive positive pressure ventilation. J Aerosol Med Pulm Drug Deliv 2012;25(2): 63-78.
11. Ari A, Atalay OT, Harwood R, Sheard MM, Aljamhan EA, Fink JB. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care 2010;55(7):845-851.
12. Dhand R. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care 2002;47(12):1406-1416.
13. Ivri E, Fink J. Aerosol delivery apparatus and method for pressureassisted breathing systems. US patent 7,290,541. November 6, 2007.
14. Longest PW, Golshahi L, Hindle M. Improving pharmaceutical aerosol delivery during noninvasive ventilation: effects of streamlined components. Ann Biomed Eng 2013;41(6):1217-1232.
15. Delvadia R, Longest PW, Byron PR. In vitro tests for aerosol deposition. I. Scaling a physical model of the upper airways to predict drug deposition variation in normal humans. J Aerosol Med 2012; 25(1):32-40.
16. Longest PW, Hindle M. Evaluation of the Respimat Soft Mist inhaler using a concurrent CFD and in vitro approach. J Aerosol Med Pulm Drug Deliv 2009;22(2):99-112.
17. Xi J, Longest PW, Martonen TB. Effects of the laryngeal jet on nanoand microparticle transport and deposition in an approximate model of the upper tracheobronchial airways. J Appl Physiol 2008; 104(6):1761-1777.
18. Longest PW, Vinchurkar S. Validating CFD predictions of respiratory aerosol deposition: effects of upstream transition and turbulence. J Biomech 2007;40(2):305-316.
19. Longest PW, Hindle M, Das Choudhuri S, Xi J. Comparison of ambient and spray aerosol deposition in a standard induction port and more realistic mouth-throat geometry. J Aerosol Sci 2008;39(7): 572-591.
20. Vinchurkar S, Longest PW. Evaluation of hexahedral, prismatic and hybrid mesh styles for simulating respiratory aerosol dynamics. Comput Fluids 2008;37(3):317-331.
21. Longest PW, Vinchurkar S. Effects of mesh style and grid convergence on particle deposition in bifurcating airway models with comparisons to experimental data. Med Eng Phys 2007;29(3):350-366.
22. Longest PW, Hindle M, Das Choudhuri S, Byron PR. Numerical simulations of capillary aerosol generation: CFD model development and comparisons with experimental data. Aerosol Sci Technol 2007; 41(10):952-973.
23. Longest PW, Kleinstreuer C, Buchanan JR. Efficient computation of micro-particle dynamics including wall effects. Comput Fluids 2004; 33(4):577-601.
24. Longest PW, Xi J. Effectiveness of direct Lagrangian tracking models for simulating nanoparticle deposition in the upper airways. Aerosol Sci Technol 2007;41(4):380-397.
25. Dhand R. New frontiers in aerosol delivery during mechanical ventilation. Respir Care 2004;49(6):666-677.
26. Longest PW, Spence BM, Holbrook LT, Mossi KM, Son Y-J, Hindle M. Production of inhalable submicrometer aerosols from conventional mesh nebulizers for improved respiratory drug delivery. J Aerosol Sci 2012;51:66-80.
27. Geller DE. Aerosol antibiotics in cystic fibrosis. Respir Care 2004; 54(5):658-670.
28. Geller DE, Weers J, Heuerding S. Development of an inhaled drypowder formulation of Tobramycin using PulmoSphereTM technology. J Aerosol Med Pulm Drug Deliv 2011;24(4):175-182.
29. Olschewski H, Hoeper MM, Behr J, Ewert R, Meyer A, Borst MM, et al. Long-term therapy with inhaled iloprost in patients with pulmonary hypertension. Respir Med 2010;104:731-740.
30. Longest PW, Hindle M. Condensational growth of combination drugexcipient submicrometer particles: comparison of CFD predictions with experimental results. Pharm Res 2012;29(3):707-721.
31. Hindle M, Longest PW. Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouththroat and upper tracheobronchial model. Pharm Res 2010;27(9): 1800-1811.
32. Tian G, Longest PW, Su G, Hindle M. Characterization of respiratory drug delivery with enhanced condensational growth (ECG) using an individual path model of the entire tracheobronchial airways. Ann Biomed Eng 2011;39(3):1136-1153.
33. Tronde A, Baran G, Eirefelt S, Lennernas H, Bengtsson UH. Miniaturized nebulization catheters: a new approach for delivery of defined aerosol doses to the rat lung. J Aerosol Med 2002;15(3):283-296.
34. Selting K, Essman S, Reinero C, Branson KR, Henry CJ, Owen N, et al. Targeted combined aerosol chemotherapy in dogs and radio-logic toxicity grading. J Aerosol Med Pulm Drug Deliv 2011;24(1): 43-48.